| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_MTO1_0003300 | Exon-Exon | chr6:74189455-74190090 | chr6:73479732-73480367 | 379 nt | 0.4670 |
| hsa_MTO1_0003400 | Exon-Exon | chr6:74189455-74190839 | chr6:73479732-73481116 | 119 nt | 0.4538 |
| hsa_MTO1_0003100 | Intron-Exon-Intron | chr6:74189455-74196484 | chr6:73479732-73486761 | 250 nt | 0.3560 |
| hsa_chr6_0619400 | Intergenic-Intergenic | chr6:74189760-74190471 | chr6:73480037-73480748 | 90 nt | 0.4444 |
| hsa_MTO1_0003900 | Exon-Exon | chr6:74189762-74190505 | chr6:73480039-73480782 | 271 nt | 0.4982 |
| hsa_MTO1_0004000 | Exon-Exon | chr6:74190398-74190839 | chr6:73480675-73481116 | 247 nt | 0.5263 |
| hsa_MTO1_0004200 | Exon-Exon | chr6:74190398-74192343 | chr6:73480675-73482620 | 377 nt | 0.4695 |
| hsa_MTO1_0004300 | Intron-Exon-Intron | chr6:74190398-74196484 | chr6:73480675-73486761 | 131 nt | 0.4809 |
| hsa_MTO1_0004400 | Intron-Exon-Intron | chr6:74190398-74200868 | chr6:73480675-73491145 | 70 nt | 0.4429 |
| hsa_MTO1_0004500 | Exon-Exon | chr6:74190398-74202075 | chr6:73480675-73492352 | 137 nt | 0.4745 |
A review consolidating existing research indicates that the circMTO1 functions as a tumor suppressor in hepatocellular carcinoma [Lee et al. DOI:10.1016/j.biopha.2018.12.052] and sponges miR-630 to reverse temozolomide chemoresistance in glioblastoma [Mehta et al. DOI:10.1016/j.pneurobio.2020.101746].